131 related articles for article (PubMed ID: 37799722)
1. Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir.
Sun Y; Dian Y; Gao Q; Deng G
Front Immunol; 2023; 14():1227905. PubMed ID: 37799722
[TBL] [Abstract][Full Text] [Related]
2. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain.
Cantenys-Molina S; Fernández-Cruz E; Francos P; Lopez Bernaldo de Quirós JC; Muñoz P; Gil-Herrera J
Clin Exp Immunol; 2021 Mar; 203(3):424-432. PubMed ID: 33187018
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Blood CD8+T Cell as a Prognostic Biomarker for Hospitalised COVID-19 Patients Without Antiviral Treatment.
Sun Y; Liu P; Zhang L; Lei S; Gao Q
Infect Drug Resist; 2024; 17():109-117. PubMed ID: 38230269
[TBL] [Abstract][Full Text] [Related]
5. Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.
Lui DTW; Chung MSH; Lau EHY; Lau KTK; Au ICH; Lee CH; Woo YC; Wong CKH; Cowling BJ
JAMA Netw Open; 2023 May; 6(5):e2314393. PubMed ID: 37204790
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping characteristics of COVID-19 patients: Peripheral blood CD8+ HLA-DR+ T cells as a biomarker for mortality outcome.
Mirsharif ES; Chenary MR; Bozorgmehr M; Mohammadi S; Hashemi SM; Ardestani SK; Beigmohammadi MT; Abdollahi A; Sadeghipour A; Kariminia A; Tuserkani F; Ghazanfari T
J Med Virol; 2023 Jan; 95(1):e28192. PubMed ID: 36192361
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and prognostic value of peripheral lymphocyte subtyping for invasive candidiasis infection in critically ill patients with non-neutropenic sepsis].
Han W; Wang H; Cui N; Zhang JH; Bai GX; Chen JW; Long Y
Zhonghua Nei Ke Za Zhi; 2020 Dec; 59(12):968-975. PubMed ID: 33256338
[No Abstract] [Full Text] [Related]
8. [Characteristics and prognostic value of peripheral blood T lymphocyte subsets in patients with severe influenza].
Geng TR; Han Y; Qiu ZF; Du TK; Jiang W; Shi JH; Qin T; Fan HW; Li TS
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):200-206. PubMed ID: 32146746
[No Abstract] [Full Text] [Related]
9. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
[TBL] [Abstract][Full Text] [Related]
10. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
11. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
Fu HY; Luo Y; Gao JP; Wang L; Li HJ; Li X; Xue L; Tang XQ; Li HW; Du YR
Biomed Res Int; 2020; 2020():2854186. PubMed ID: 33015160
[TBL] [Abstract][Full Text] [Related]
12. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
13. CD4+ and CD8+ cell counts are significantly correlated with absolute lymphocyte count in hospitalized COVID-19 patients: a retrospective study.
Liana P; Samosir AP; Sari NP; Andriani RAL; Verdiansah V; Hidayatullah H; Ahmad Z; Umar TP
PeerJ; 2023; 11():e15509. PubMed ID: 37377785
[TBL] [Abstract][Full Text] [Related]
14. Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients.
Kim MK; Lee KS; Ham SY; Choi YY; Lee E; Lee S; Lee B; Jeon J; Chin B; Kim Y; Kim G; Jang HC; Choi JP; Park SW
J Korean Med Sci; 2023 Sep; 38(35):e272. PubMed ID: 37667578
[TBL] [Abstract][Full Text] [Related]
15. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H
Front Immunol; 2021; 12():568789. PubMed ID: 34149679
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
[TBL] [Abstract][Full Text] [Related]
17. Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.
Deng G; Li D; Sun Y; Jin L; Zhou Q; Xiao C; Wu Q; Sun H; Dian Y; Zeng F; Pan P; Shen M
J Med Virol; 2023 Apr; 95(4):e28756. PubMed ID: 37185838
[TBL] [Abstract][Full Text] [Related]
18. The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective study.
Wang L; Chen J; Zhao J; Li F; Lu S; Liu P; Liu XH; Huang Q; Wang H; Xu QN; Liu X; Yu S; Liu L; Lu H
Ther Adv Respir Dis; 2021; 15():17534666211049739. PubMed ID: 34632871
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.
Rezaei M; Marjani M; Mahmoudi S; Mortaz E; Mansouri D
Int Arch Allergy Immunol; 2021; 182(3):254-262. PubMed ID: 33498051
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
